You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Predictive Biosciences to partner with ARUP Laboratories on bladder-cancer tests

Predictive Biosciences announced a partnership with ARUP Laboratories that will offer the company’s molecular diagnostic bladder cancer tests to ARUP’s national network of clients.

Lexington-based Predictive Biosciences specializes in molecular diagnostic cancer assays and provides molecular pathology services for urologists.

Continue reading below

Under a non-exclusive agreement, ARUP, a lab at the University of Utah, will offer Predictive’s CertNDx Bladder Cancer Assays in its comprehensive test menu to hospitals, health care providers, academic medical centers, and military and government facilities around the country, the company said in a press release.

In a statement, Predictive Biosciences chief executive Pierre Cassigneul said: “We are excited to begin our partnership with ARUP, a laboratory that shares our passion for innovation and technology. We believe this alliance will greatly expand the availability of our bladder cancer products to a wider network of leading medical facilities that can benefit from CertNDx testing.”

The CertNDx Bladder Cancer Assay is a non-invasive, urine-based test to assess patients with hematuria and to monitor for bladder cancer recurrence following treatment.

ARUP Laboratories is a national reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of